Back

Immunotherapy in oncology: implications for cardiovascular risk

4 April 2025 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Inflammation and infection as cardiovascular risk factors: translating basic research into preventive care Leukocytes, Inflammation, Immunity EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Maria Laura Canale

Versilia Hospital, Lido Di Camaiore (Italy)

3 More presentations in this session

Presentation thumbnail
Cardio-rheumatology: what can we learn from rheumatoid arthritis treatment?
Doctor A. Semb (Oslo, NO)
Slides Video
Presentation thumbnail
Chronic inflammation in atherosclerosis: how to deal with it
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Inflammation and infection as cardiovascular risk factors: translating basic research into preventive care - discussion
Video

Access the full session

Session thumbnail
Inflammation and infection as cardiovascular risk factors: translating basic research into preventive care

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Case 3: late cardiovascular toxicity during immune checkpoint inhibitors therapy
thumbnail
Congress Presentation
Update on immunotherapy-related cardiotoxicity: checkpoint inhibitors, CAR-T cells, and beyond
thumbnail
Congress Presentation
Novel targeted cancer therapies which can cause cardiovascular complications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources